Hostname: page-component-55f67697df-2mk96 Total loading time: 0 Render date: 2025-05-12T19:03:35.920Z Has data issue: false hasContentIssue false
  • English
  • Français

Depression ‘Revealed’ in Schizophrenia

Published online by Cambridge University Press:  29 January 2018

Steven R. Hirsch
Get access Rights & Permissions [Opens in a new window]

Extract

Since Helmchen and Hippius (1967) noted that half a sample of 120 schizophrenics had depressive symptoms at the time of admission, more than 30 papers have appeared associating depressive symptoms in schizophrenics with neuroleptic medication (Ananth and Chadirian, 1980). Many authors and clinicians in fact think that a causal relationship has been proven, and the term ‘pharmacogenic depression’ and the associated concept ‘akinetic depression’ have come into use. The assumptions underlying these concepts and the evidence to support them need critical examination. They will be considered with the results of more recent studies which answer some of the outstanding questions, but in turn raise new ones about the relationship of schizophrenia and depression to their underlying pathophysiology.

Type
Comments
Information
The British Journal of Psychiatry , Volume 140 , Issue 4 , April 1982 , pp. 421 - 423
Copyright
Copyright © Royal College of Psychiatrists, 1982 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Ananth, J. & Chadirian, A. M. (1980) Drug induced mood disorder. International Pharmacopsychiatry, 15, 58–73.Google Scholar
Donlon, P. T., Rada, R. T. & Arora, K. K. (1976) Depression and the reintegration phase of acute schizophrenia. American Journal of Psychiatry, 133, 1265–8.Google ScholarPubMed
Helmchen, H. & Hippius, H. (1967) Depressive Syndrome im Verlauf neuronleptischer Therapie. Nervenarzt, 38, 445.Google Scholar
Hirsch, S. R., Gaind, R., Rohde, P. D. et al (1973) Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: A double-blind placebo trial. British Medical Journal, i, 633–7.Google Scholar
Johnson, D. A. W. (1981) Studies of depressive symptoms in schizophrenia. British Journal of Psychiatry, 139, 89–101.CrossRefGoogle ScholarPubMed
Johnson, D. A. W. (1981) Studies of depressive symptoms in schizophrenia: III. A double-blind trial of orphenadrine against placebo. British Journal of Psychiatry, 139, 96–7.Google Scholar
Knights, A., Okasha, M. S., Salih, M. et al (1979) Depressive and extrapyramidal symptoms and clinical effects: A trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients. British Journal of Psychiatry, 135, 515–23.Google Scholar
Knights, A. & Hirsch, S. R. (1981) ‘Revealed’ depression and drug treatment for schizophrenia. Archives of General Psychiatry, 38, 806–11.CrossRefGoogle ScholarPubMed
Möller, H. J. & Von Zerssen, D. (1981) Depressive Symptomatik in stationären Behandlungsverlauf von 280 schizophrenen Patienten. Pharmacopsychiatria, 14, 172–9.CrossRefGoogle Scholar
Quitkin, F., Rifkin, A., Kane, J. et al (1978) Long-acting oral vs injectable antipsychotic drugs in schizophrenics: A one-year double-blind comparison in multiple episode schizophrenics. Archives of General Psychiatry, 35, 889–92.CrossRefGoogle ScholarPubMed
Shanfield, S., Tucher, G. J., Harrow, M. et al (1970) The schizophrenic patient and depressive symptomatology. Journal of Nervous and Mental Disease, 151, 203–10.Google Scholar
Van Putten, T. & May, P. R. A. (1978) ‘Akinetic depression’ in schizophrenia. Archives of General Psychiatry, 35, 1101–7.CrossRefGoogle ScholarPubMed
Wing, J. K., Cooper, J. E. & Sartorius, N. (1974) The Measurement and Classification of Psychiatric Symptoms. London: Cambridge University Press.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.